KAER Biotherapeutics has announced the launch of the AeroPulsR aerosol device for delivery of high doses of aqueous aerosols in critical care settings. According to KAER, the AeroPulsR can deliver liquids of viscosities up to 50 cP as aerosols with particle sizes in the 2-4 μm range. The device also can deliver aerosols in continuous, periodic, or spontaneous … [Read more...] about KAER Bio launches AeroPulsR high dose delivery system for critical care use
Products and Services
Nemera and Nipro announce compatibility of Nemera’s UniSpray nasal pump and Nipro’s unit dose vials
Nemera and Nipro Pharma Packaging have announced the conclusion of compatibility testing of Nemera’s UniSpray nasal pump with Nipro’s unit dose "microvials." According to the companies, the tests demonstrated complete compatibility and meet requirements for reliability and dose delivery. Nemera announced the launch of the UniSpray single metered dose nasal pump, … [Read more...] about Nemera and Nipro announce compatibility of Nemera’s UniSpray nasal pump and Nipro’s unit dose vials
DFE Pharma adds services for DPIs at Center of Excellence in Hyderabad
Lactose supplier DFE Pharma has announced the availability of analytical services for dry powder inhaler formulations at its Closer to the Formulator (C2F) Center of Excellence in Hyderabad, India, in response to growing demand. According to DFE, the center opened in 2022 but only offered services for oral solid dosage forms until now. Newly available services at … [Read more...] about DFE Pharma adds services for DPIs at Center of Excellence in Hyderabad
Lonza to develop spray dried formulations of a dry powder intranasal biologic for Iconovo
Spray drying experts Lonza will develop spray dried dry powder formulations for delivery by Iconovo's ICOone Nasal device, the companies announced. According to the announcement, the collaboration involves "a reformulated substance for obesity." In May 2024, Iconovo said that it intended to develop inhaled GLP-1 receptor agonists for the treatment of … [Read more...] about Lonza to develop spray dried formulations of a dry powder intranasal biologic for Iconovo
Phillips Medisize parent company Molex completes acquisition of Vectura
Phillips Medisize announced that its parent company Molex has completed its acquisition of inhalation CDMO Vectura, which was initially announced in September 2024. According to the announcement, the acquisition covers all of Vectura's assets in addition to its OINDP analysis and development services business, which employs 350 people. Vectura's intellectual property … [Read more...] about Phillips Medisize parent company Molex completes acquisition of Vectura
Merxin and OECHSLERhealth partner on SMI development services
Merxin Ltd and contract device manufacturer OECHSLERhealth have announced the formation of a strategic partnership called The SMI PowerHouse for manufacturing of Merxin's MRX004 soft mist inhaler, a generic version of the Respimat device. According to the announcement, the two companies have worked together since 2018. Merxin and OECHSLERhealth say that the … [Read more...] about Merxin and OECHSLERhealth partner on SMI development services
Intertek and CrystecPharma partner on DPI development services
Intertek, which provides a wide range of testing services for OINDPs, has announced a new partnership with particle engineering specialist CrystecPharma for creation of a "fast to clinic" development platform for dry powder inhaler formulations. The company says that as of January 2025, the new platform will halve the time typically required to develop DPI … [Read more...] about Intertek and CrystecPharma partner on DPI development services
Bespak and OzUK extend their partnership on LGWP MDI development services
Expanding on a partnership established in 2023, and following the closure of Bespak's OINDP development facilities in North Carolina, CDMO Bespak and CRO OzUK say that they will now offer continuity of low global warming potential (LGWP) propellant development projects between the two companies, with projects started at OzUK facilities then transfering to Bespak for … [Read more...] about Bespak and OzUK extend their partnership on LGWP MDI development services
Orbia announces planned expansion of HFA 152a manufacturing capacity
Orbia Fluor & Energy Materials (formerly Koura Global) has announced plans for a new manufacturing facility for its Zephex HFA 152a LGWP MDI propellant, saying that the plant will produce significantly more 152a than the first plant that was opened in 2022. The announcement does not specify the size of the increase in capacity or the size of the investment. The … [Read more...] about Orbia announces planned expansion of HFA 152a manufacturing capacity
Hovione completes expansion of spray drying facilities in US and Ireland
CDMO Hovione has announced the completion of expansion projects at its facilities in East Windsor, NJ, USA and Ringaskiddy, Cork, Ireland that its says will provide a significant increase in the company's spray drying capacity and will create more than 40 jobs. In November 2021, Hovione said that it was launching a $170 million project to increase capacity at its US, … [Read more...] about Hovione completes expansion of spray drying facilities in US and Ireland